Stay updated on Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 on the page, a minor update with no changes to core study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:41:53.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:09:28.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Updates are primarily UI and metadata changes (Show glossary, last QC submission details, and revision notes) and do not affect core study content such as eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-01-28T20:29:06.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page, with no visible changes to trial details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:12:48.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section including a Texas site (Houston, TX) and updated revision to v3.3.3; removed the HHS Vulnerability Disclosure link and the previous Texas Locations entry.
    Difference
    0.2%
    Check dated 2025-12-23T22:05:52.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Updated revision label from v3.2.0 to v3.3.2 across the page, representing a minor platform version change without altering study content or its purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:23:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Breast Cancer Clinical Trial page.